Stavropoulos S William, Kim Hans, Clark Timothy W I, Fairman Ronald M, Velazquez Omaida, Carpenter Jeffrey P
Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19010, USA.
J Vasc Interv Radiol. 2005 Jun;16(6):857-61. doi: 10.1097/01.RVI.0000156495.66062.62.
Translumbar embolization was used to treat 11 type 2 endoleaks in nine patients with the liquid embolic agent n-butyl cyanoacrylate (NBCA). Nine of the embolizations were performed with a combination of stainless-steel coils and NBCAJ and the other two were performed with NBCA alone. There was complete occlusion on initial computed tomographic (CT) angiography in six of nine patients (66%), including the two cases treated with NBCA alone. Persistent endoleak on initial CT angiography occurred in three of nine patients (33%). Two of these patients underwent successful repeated embolization with NBCA. Aneurysm size remained unchanged in four patients (44%), decreased in four patients (44%), and increased in one patient (11%). No complications occurred. Initial results with the use of NBCA for endoleak embolization are encouraging.
采用经腰动脉栓塞术,使用液体栓塞剂氰基丙烯酸正丁酯(NBCA)治疗9例患者的11处2型内漏。9次栓塞术联合使用不锈钢圈和NBCA,另外2次仅使用NBCA。9例患者中有6例(66%)在初次计算机断层扫描(CT)血管造影时实现完全闭塞,包括仅用NBCA治疗的2例。9例患者中有3例(33%)在初次CT血管造影时存在持续性内漏。其中2例患者再次使用NBCA成功进行栓塞。4例患者(44%)的动脉瘤大小保持不变,4例患者(44%)的动脉瘤大小减小,1例患者(11%)的动脉瘤大小增大。未发生并发症。使用NBCA进行内漏栓塞的初步结果令人鼓舞。